510(k) Report

510(k) · Cleared

Cleared

Analgesic Pulser, Model AP-439

K993229510(k) TraditionalCleared Feb 2, 2001494-day reviewClass II21 CFR 882.5890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Johari Electro-Tech Co. · GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

Cleared on Feb 2, 2001 as substantially equivalent to K964028 (Mettler Electronics Corp., 1997) after a 494-day review. Its family tree reaches back 1 generation to 1997. 1 later device descends from it.

Decided
Feb 2, 2001
Review
494 days
Class
Class II
Product code
GZJ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K964028 (1997). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2002: 1 descendant clearedK964028 · Sys Stim 226 · Mettler Electronics Corp. · 19971995200020052010201520202025
Descendants, by generation 1 generation forward: 1 descendant K964028 · Sys Stim 226 · Mettler Electronics Corp. · 19970
  1. Root · 1 generation backK964028 Sys Stim 226Mettler Electronics Corp. · 1997
  2. This deviceK993229 Analgesic Pulser, Model AP-439Johari Electro-Tech Co. · 2001
  3. Descendant · cites it directly · 0 of its ownK024036 Product Line-Combo Stimulator/Sequential Stimulator, Model IF-5000Johari Digital Healthcare, Ltd. · 2002

Most influential descendants

Showing 1 of 1 · See all
  • K024036Product Line-Combo Stimulator/Sequential Stimulator, Model IF-5000Johari Digital Healthcare, Ltd. · 2002 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K964028Sys Stim 226Mettler Electronics Corp.1997—
0 (this device)K993229Analgesic Pulser, Model AP-439Johari Electro-Tech Co.2001—
+1K024036Product Line-Combo Stimulator/Sequential Stimulator, Model IF-5000Johari Digital Healthcare, Ltd.2002—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200210
FIG. 1 — Lineage of K993229, 1997–2002Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZJ device

  1. #1 K252767 actiTENS miniscore 13.1 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K964028Sys Stim 226
Summary page 2
…Physical Medicine (Per 21 CFR Section 890) and Neurology (Per 21 CFR Section 882.5890). Legally Marketed Device I (a) Sys stim 226 : Muscle Stimulator 510(k) Number K964028 (b) Sys stim 206 Manufacturer : Mettler Electronics Corp. Address : 1333 S. Claudia St. Anaheim Ca. 92805 Tel. : 001 (714) 533…
Mettler Electronics Corp.1997—
*—Sys stim 206
Named without a submission number
—
*—Sportx
Named without a submission number
—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K024036Product Line-Combo Stimulator/Sequential Stimulator, Model IF-5000Johari Digital Healthcare, Ltd.20020

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K024036 (Johari Digital Healthcare, Ltd., 2002) has gone furthest, with 0 descendants of its own.

How does its category compare?

All GZJ devices

GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GZJ

1in 2025

2007: 132008: 112009: 162010: 52011: 52012: 122013: 22014: 42015: 32016: 32017: 32018: 22019: 32020: 42021: 32022: 42023: 12024: 32025: 12026 (partial year): 2
2007high 16 (2009) · low 1 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZJ

207in 2024

2007: 223 days median2008: 136 days median2009: 155 days median2010: 232 days median2011: 168 days median2012: 154 days median2014: 344 days median2015: 202 days median2016: 163 days median2017: 113 days median2019: 156 days median2020: 183 days median2021: 231 days median2022: 175 days median2024: 207 days median
2007high 344 (2014) · low 113 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZJ

1in 2011

2007: 42008: 12011: 1
2007high 4 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GZJ

13in 2025

2007: 42008: 452009: 172010: 222011: 222012: 202013: 102014: 232015: 182016: 322017: 582018: 212019: 72020: 102021: 52022: 42023: 392024: 122025: 13
2007high 58 (2017) · low 4 (2007)2025

MAUDE reports naming product code GZJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071322344
200811136145
200916155017
20105232022
20115168122
201212154020
20132—010
20144344023
20153202018
20163163032
20173113058
20182—021
2019315607
20204183010
2021323105
2022417504
20231—039
20243207012
20251—013
20262—0—

What is it indicated for?

(A) Interferential current stimulation, Premodulated Bipolar Mode and Faradic Stimulation Mode is indicated for; 1 Symptomatic relief and management of chronic (long term) intractable pain. 2 Adjunctive treatment in the management of post-surgical and post-traumatic, acute pain conditions. (B) Electrical Muscle Stimulation (Russian and Galvanic-Interrupted) is indicated for: Relaxation of Muscle spasm. Prevention or Retardation of disuse atrophy.…

Read the full statement (93 words)

(A) Interferential current stimulation, Premodulated Bipolar Mode and Faradic Stimulation Mode is indicated for;

1 Symptomatic relief and management of chronic (long term) intractable pain.

2 Adjunctive treatment in the management of post-surgical and post-traumatic, acute pain conditions.

(B) Electrical Muscle Stimulation (Russian and Galvanic-Interrupted) is indicated for:

Relaxation of Muscle spasm.

Prevention or Retardation of disuse atrophy.

Increasing, local blood circulation.

Muscle re-education.

Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis.

6. Maintaining or increasing range of motion

(C) Galvanic-DC Continuous mode is indicated for:-

1. Relaxation of muscle spasm.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K993229: Analgesic Pulser, Model AP-439.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K993229

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026